Stromal-cell-derived Factor 1-α Promotes Tumor Progression in Colorectal Cancer

다국어 초록 (Multilingual Abstract)

Purpose: Although stromal-cell-derived factor (SDF)-1α is suggested to be involved in tumorigenicity and tumor angiogenesis,the clinicopathological significance of its expression in colorectal cancers is not fully understood. We examined SDF-1α expression in colorectal cancers and investigated its relationship to clinicopathological features such as tumor staging, lymph-node metastasis, vascular invasion (VI), lymphatic invasion (LI) and neural invasion (NI).
Methods: Specimens of 83 primary colorectal cancers were examined immunohistochemically, and the relationships between clinicopathological features and SDF-1α expression were analyzed. To compare the expressions between the normal colon tissue and colorectal cancer tissues, we performed Western blot analyses.
Results: According to the Western blot analyses, SDF-1α was more highly expressed in colorectal carcinoma tissues than in normal colonic mucosa (20/21). According to the immunohistochemical stain, SDF-1α was associated with nodal status,distant metastasis, tumor staging, VI and LI. SDF-1α expression had a significant prognostic value for overall survival.
Kaplan-Meier plots of survival in patients with high SDF-1α showed that high SDF-1α expression was associated with a shorter overall survival. However, no association was found between SDF-1α expression and other pathologic or clinical variables, including age, gender, degree of differentiation, and presence of perineural invasion.
Conclusion: The expression of SDF-1α might be associated with tumor progression in colorectal cancer. Inhibition of SDF-1α could be a therapeutic option in colorectal cancer patients.

참고문헌 (Reference)

1 Bolontrade MF, "Vasculogenesis plays a role in the growth of Ewing’s sarcoma in vivo" 8 : 3622-3627, 2002

2 Taichman RS, "Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone" 62 : 1832-1837, 2002

3 Dwenger A, "Transplanted bone marrow cells preferentially home to the vessels of in situ generated murine tumors rather than of normal organs" 22 : 86-92, 2004

4 Rafii S, "Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration" 9 : 702-712, 2003

5 Folkman J, "The role of angiogenesis in tumor growth" 3 : 65-71, 1992

6 Almofti A, "The clinicopathological significance of the expression of CXCR4 protein in oral squamous cell carcinoma" 25 : 65-71, 2004

7 Tilton B, "Signal transduction by CXC chemokine receptor 4. Stromal cellderived factor 1 stimulates prolonged protein kinase B and extracellular signal-regulated kinase 2 activation in T lymphocytes" 192 : 313-324, 2000

8 De Falco E, "SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells" 104 : 3472-3482, 2004

9 Darash-Yahana M, "Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis" 18 : 1240-1242, 2004

10 Shibuta K, "Reduced expression of the CXC chemokine hIRH/SDF-1alpha mRNA in hepatoma and digestive tract cancer" 73 : 656-662, 1997

11 Abdalla EK, "Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases" 239 : 818-825, 2004

12 Uchida D, "Possible role of stromal-cell-derived factor-1/ CXCR4 signaling on lymph node metastasis of oral squamous cell carcinoma" 290 : 289-302, 2003

13 Ramsoekh D, "Population screening for colorectal cancer: faeces, endoscopes or X-rays?" 29 : 185-194, 2007

14 Muller A, "Involvement of chemokine receptors in breast cancer metastasis" 410 : 50-56, 2001

15 Santarelli JG, "Incorporation of bone marrow-derived Flk-1-expressing CD34+ cells in the endothelium of tumor vessels in the mouse brain" 59 : 374-382, 2006

16 Lyden D, "Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth" 7 : 1194-1201, 2001

17 Du R, "HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion" 13 : 203-220, 2008

18 Vlahakis SR, "G protein-coupled chemokine receptors induce both survival and apoptotic signaling pathways" 169 : 5546-5554, 2002

19 Jiang YP, "Expression of chemokine CXCL12 and its receptor CXCR4 in human epithelial ovarian cancer: an independent prognostic factor for tumor progression" 103 : 226-233, 2006

20 Jin DK, "Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes" 12 : 557-567, 2006

21 Ishigami S, "Clinical implication of CXCL12 expression in gastric cancer" 14 : 3154-3158, 2007

22 Jo DY, "Chemotaxis of primitive hematopoietic cells in response to stromal cell-derived factor-1" 105 : 101-111, 2000

23 Hamilton SR, "Carcinoma of the colon and rectum, In Pathology and genetics of tumours of the digestive system" IARC Press 105-119, 2000

24 Parker SL, "Cancer statistics" 47 : 5-27, 1997

25 Miao Z, "CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature" 104 : 15735-15740, 2007

26 Schrader AJ, "CXCR4/CXCL12 expression and signalling in kidney cancer" 86 : 1250-1256, 2002

27 Sun X, "CXCL12/ CXCR4 / CXCR7 chemokine axis and cancer progression" 29 : 709-722, 2010

28 Salmaggi A, "CXCL12 expression is predictive of a shorter time to tumor progression in low-grade glioma: a single-institution study in 50 patients" 74 : 287-293, 2005

29 Strieter RM, "CXC chemokines in angiogenesis of cancer" 14 : 195-200, 2004